An aqueous extract of green tea Camellia sinensis increases expression of Th1 cell-specific anti-asthmatic markers

International Journal of Molecular Medicine

Volumn 22, Issue 6, 2008, Pages 763-767

  Heo, Jin Chul ^a,b   Rho, Jae Rang ^b   Kim, Tae Ho ^c,d   Kim, Shin Yoon ^c,d   Lee, Sang Han ^a  

^a Kyungpook National University   (South Korea)

^b Chungnam National University   (South Korea)

^c Kyungpook National University School of Medicine   (South Korea)

^d Kyungpook National University Hospital   (South Korea)

Author keywords

Aqueous extract; Biomarkers; Camellia sinensis; Ovalbumin challenge model

Indexed keywords

CYTOKINE; EOSIN; GAMMA INTERFERON; GREEN TEA EXTRACT; HEMATOXYLIN; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; LYMPHOTOXIN; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CD4 LYMPHOCYTE COUNT; CELL SPECIFICITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL;

ANIMALS; ANTIGENS, CD4; ASTHMA; BIOLOGICAL MARKERS; CAMELLIA SINENSIS; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; INTERLEUKIN-10; LUNG; LYMPHOTOXIN-ALPHA; MALE; MICE; MICE, INBRED BALB C; OVALBUMIN; PHYTOTHERAPY; PLANT EXTRACTS; TH1 CELLS;

EID: 65449132431     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000083     Document Type: Article

References (28)

1. Cabrera C, Artacho R and Giménez R: Beneficial effects of green tea: a review. J Am Coll Nutr 25: 79-99, 2006.
2. Monobe M, Ema K, Kato F and Maeda-Yamamoto M: Immunostimulating activity of a crude polysaccharide derived from green tea (Camellia sinensis) extract. J Agric Food Chem 56: 1423-1427, 2008.
3. Sliva D: Suppression of cancer invasiveness by dietary compounds. Mini Rev Med Chem 8: 677-688, 2008.
4. Cartier A and Mal JL: Occupational asthma due to tea dust. Thorax 45: 203-206, 1990.
5. Shirai T, Sato A and Hara Y: Epigallocatechin gallate. The major causative agent of green tea-induced asthma. Chest 106: 1801-1805, 1994.
6. Shirai T, Reshad K, Yoshitomi A, Chida K, Nakamura H and Taniguchi M: Green tea-induced asthma: relationship between immunological reactivity, specific and non-specific bronchial responsiveness. Clin Exp Allergy 33: 1252-1255, 2003.
7. Murr C, Schroecksnadel K, Winkler C, Ledochowski M and Fuchs D: Antioxidants may increase the probability of developing allergic diseases and asthma. Med Hypotheses 64: 973-977, 2005.
8. Bani D, Giannini L, Ciampa A, Masini E, Suzuki Y, Menegazzi M, Nistri S and Suzuki H: Epigallocatechin-3-gallate reduces allergen-induced asthma-like reaction in sensitized guinea pigs. J Pharmacol Exp Ther 317: 1002-1011, 2006.
9. Kim SH, Park HJ, Lee CM, Choi IW, Moon DO, Roh HJ, Lee HK and Park YM: Epigallocatechin-3-gallate protects toluene diisocyanate-induced airway inflammation in a murine model of asthma. FEBS Lett 580: 1883-1890, 2006.
10. Ki SH, Jun CD, Suk K, Choi BJ, Lim H, Park S, Lee SH, Shin HY, Kim DK and Shin TY: Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. Toxicol Sci 91: 123-131, 2006.
11. Hwang YK, Chun JS, Yoo PD, Ma JY, Hyun BH, Kim SU, Chang KT and Lee SH: Occlusal reduction of unilateral molars influences change of stress-related hormones in rats. Scand J Lab Anim Sci 31: 73-77, 2004.
12. Heo JC, Woo SW, Kweon MA, Park JY, Lee HK, Son M, Rho JR and Lee SH: Aqueous extract of the Helianthus annuus seed alleviates asthmatic symptoms in vivo. Int J Mol Med 21: 57-61, 2008.
13. Wu AY, Chik SC, Chan AW, Li Z, Tsang KW and Li W: Anti-inflammatory effects of high-dose montelukast in an animal model of an acute asthma. Clin Exp Allergy 33: 359-366, 2003.
14. Lee E, Ha K, Yook JM, Jin MH, Seo CS, Son KH, Kim HP, Bae KH, Kang SS, Son JH and Chang HW: Anti-asthmatic activity of an ethanol extract from Saururus chinensis. Biol Pharm Bull 29: 211-215, 2006.
15. Choi JH, Oh SW, Kang MS, Kwon HJ, Oh GT and Kim DK: Trichostatin A attenuates airway inflammation in mouse asthma model. Clin Exp Allergy 35: 89-96, 2005.
16. Roos-van Groningen MC, Eikmans M, Baelde HJ, de Heer E and Bruijn JA: Improvement of extraction and processing of RNA from renal biopsies. Kidney Int 65: 97-105, 2004.
17. An SM, Park CH, Heo JC, Park JY, Woo SW, Seo JH, Lee MS, Cho KJ, Cho HS, Shin HM and Lee SH: Gastrodia elata Blume protects against stress-induced gastric mucosal lesions in mice. Int J Mol Med 20: 209-215, 2007.
18. Heo JC, Park JY, Woo SU, Rho JR, Lee HJ, Kim SU, Kho YH and Lee SH: Dykellic acid inhibits cell migration and tube formation by RhoA-GTP expression. Biol Pharm Bull 29: 2256-2259, 2006.
19. Kim DY, Ryu SY, Lim JE, Lee YS and Ro JY: Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model. Eur J Pharmacol 557: 76-86, 2007.
20. Ponikau JU, Sherris DA, Kephart GM, Kern EB, Gaffey TA, Tarara JE and Kita H: Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: is the histopathology similar to asthma? J Allergy Clin Immunol 112: 877-882, 2003.
21. Falkeholm L, Grant CA, Magnusson A and Moller E: Xylene-free method for histological preparation: a multicentre evaluation. Lab Invest 81: 1213-1221, 2001.
22. Striz I, Mio T, Adachi Y, Robbins RA, Romberger DJ and Rennard SI: IL-4 and IL-13 stimulate human bronchial epithelial cells to release IL-8. Inflammation 23: 545-555, 1999.
23. Kelly L, McCan KL and Imani F: Transforming growth factor beta enhances respiratory syncytial virus replication and tumor necrosis factor-α induction in human epithelial cells. J Virol 81: 2880-2886, 2007.
24. Wegmann M, Fehrenbach H, Fehrenbach A, Held T, Schramm C, Garn H and Renz H: Involvement of distal airways in a chronic model of experimental asthma. Clin Exp Allergy 35: 1263-1271, 2005.
25. Gentile DA, Doyle WJ, Zeevi A, Howe-Adams J, Trecki J and Skoner DP: Association between TNF-alpha and TGF-beta genotypes in infants and parental history of allergic rhinitis and asthma. Hum Immunol 65: 347-351, 2004.
26. Clarke JO and Mullin GE: A review of complementary and alternative approaches to immunomodulation. Nutr Clin Pract 23: 49-62, 2008.
27. Brightling C, Berry M and Amrani Y: Targeting TNF-α, a novel therapeutic approach for asthma. J Allergy Clin Immunol 121: 5-10, 2008.
28. Lei Z, Liu G, Huang Q, Lv M, Zu R, Zhang GM, Feng ZH and Huang B: SCF and IL-31 rather than IL-17 and BAFF are potential indicators in patients with allergic asthma. Allergy 63: 327-332, 2008.